- Report
- October 2024
- 197 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 194 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- April 2025
- 137 Pages
Global
From €5369EUR$5,600USD£4,486GBP
Medical biopolymers are bioplastics used in the medical industry. They are biodegradable, biocompatible, and non-toxic materials that can be used in a variety of medical applications, such as implants, prosthetics, and drug delivery systems. Medical biopolymers are typically derived from renewable sources, such as corn, sugarcane, and other plant-based materials. They are also often used in combination with other materials, such as metals, ceramics, and polymers, to create more complex medical devices.
Medical biopolymers offer a number of advantages over traditional materials, such as improved biocompatibility, reduced risk of infection, and improved durability. They are also more cost-effective than traditional materials, making them attractive to medical device manufacturers.
Some of the major companies in the medical biopolymer market include BASF, DowDuPont, Corbion, NatureWorks, and Novamont. These companies produce a variety of biopolymers for medical applications, including polylactic acid, polyhydroxyalkanoates, and polycaprolactone. Show Less Read more